REBECCA EVANS: Open Payments
NPI 1093352791 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,633 in 105 payments from 14 companies in 2025. Trend: 2023 $2,342 · 2024 $2,728 · 2025 $2,633
Food & beverage: $2,532Education: $101
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $646 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $478 |
| Janssen Pharmaceuticals, Inc | 10 | $332 |
| Neurocrine BioSciences, Inc. | 7 | $275 |
| Vanda Pharmaceuticals Inc. | 11 | $243 |
| Axsome Therapeutics, Inc. | 13 | $192 |
| Otsuka America Pharmaceutical, Inc. | 9 | $137 |
| Teva Pharmaceuticals USA, Inc. | 3 | $130 |
| E.R. Squibb & Sons, L.L.C. | 3 | $71 |
| Collegium Pharmaceutical, Inc. | 3 | $50 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, FANAPT, Auvelity, SPRAVATO, INVEGA SUSTENNA, REXULTI.
Industry payments across CA — which companies pay providers there.
